ClinicalTrials.gov
public full text
Public Domain
Cephalon Decitabine, Arsenic Trioxide and Ascorbic Acid for Myelodysplastic Syndrome
This will be an open-label, non-randomized trial pilot phase II trial open to patients with myelodysplastic syndrome. The purpose of the study is to find out if the combination of decitabine, arsenic trioxide and ascorbic acid is safe.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- To Assess the Relative Bioavailability (BA) of TRIUMEQ® and Dolutegravir and Lamivudine (DTG/3TC) Pediatric Dispersible Tablet Formulations in Healthy Volunteers#856193
- desloratadinum 5 mg#279979
- Desarrollo y validación de una metodología analítica para la determinación de ocratoxina A en muestras de músculo de pollo, a través de cromatografía líquida de ultra rendimiento acoplada a un detector de masas de triple cuadrupolo (UPLC-MS/MS)#1135701
- A Study of Single Dose of ABT-333 in Healthy Male Adults#850268
- Bioequivalence Evaluation of a New and Current Tablet of ASP015K#1214072
Record · ID 1438216
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive